Quick Answer
Olema Pharmaceuticals, Inc. reported Earnings Per Share Diluted of $1.87 (loss) per share for the year ending 2025.
- Olema Pharmaceuticals, Inc. showed an increase of +15.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Olema Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Olema Pharmaceuticals, Inc.'s Earnings Per Share Diluted has declined by 12.7%.
- Historical annual values: Fiscal year 2025: $1.87 (loss) per share | Fiscal year 2024: $2.20 (loss) per share | Fiscal year 2023: $2.14 (loss) per share | Fiscal year 2022: $2.62 (loss) per share | Fiscal year 2021: $1.80 (loss) per share | Fiscal year 2020: $3.42 (loss) per share | Fiscal year 2019: $1.66 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: